Tofacitinib oral sustained release dosage forms | Patent Number 11253523

US 11253523 B2
Application Number16817689
Publication NumberUS 20200206232 A1
Pendency1 year, 11 months, 16 days
Filled DateMar 13, 2020
Priority DateMar 16, 2013
Publication DateJul 2, 2020
Expiration DateMar 15, 2033
Inventor/ApplicantsManisha Lamba
Thomas C. Stock
Joseph Kushner, IV
Sriram Krishnaswami
Scott Max Herbig
ExaminesGOTFREDSON, GAREN
Art Unit1619
Technology Center1600
Assignments
Pfizer Legal Division 2
Current
Pfizer Legal Division 2Pfizer
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.